ANTINUCLEAR ANTIBODIES INDUCED BY ANTI-TNF ALPHA AND ITS IMPACT IN CLINICAL RESPONSE TO TREATMENT IN RHEUMATOID ARTHRITIS

被引：0
|
作者：
Fonseca, R. [1 ]
Vieira, R. [1 ]
Madureira, P. [1 ]
Rosa-Goncalves, D. [1 ]
Aguiar, F. [1 ]
Rocha, T. [1 ]
Bernardo, A. [1 ]
Mariz, E. [1 ]
Bernardes, M. [1 ]
Costa, L. [1 ]
机构：
[1] Sao Joao Hosp Ctr, Rheumatol, Oporto, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.6269
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0365
引用
收藏
页码：558 / 558
页数：1
相关论文
共 50 条
  • [41] Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment
    Ivica Lazúrová
    Ľubomír Tomáš
    Clinical Reviews in Allergy & Immunology, 2017, 52 : 323 - 332
  • [42] The emerging role of anti-TNF therapy in the treatment of rheumatoid arthritis
    Lipsky, PE
    AMERICAN JOURNAL OF MANAGED CARE, 1999, 5 (08): : S506 - S509
  • [43] FCGR2A Polymorphism and Response to Anti-TNF Treatment in Rheumatoid Arthritis.
    Avila, G.
    Tornero, Jesus
    Fernandez Nebro, Antonio
    Blanco, Francisco
    Gonzalez-Alvaro, Isidoro
    Canete, Juan D.
    Maymo, Joan
    Ballina, Javier
    Fernandez Gutierrez, Benjamin
    Olive, Alejandro
    Corominas, Hector
    Erra, Alba
    Tortosa, Rauel
    America Lopez-Lasanta, Maria
    Aterido, Adria
    Julia, Antonio
    Marsal, Sara
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S496 - S496
  • [44] POWER DOPPLER ULTRASOUND MONITORING OF RESPONSE TO ANTI-TNFα TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Iagnocco, A.
    Ceccarelli, F.
    Perricone, C.
    Finucci, A.
    Gattamelata, A.
    Iorgoveanu, V.
    Valesini, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1113 - 1114
  • [45] COLLAPSING GLOMERULOPATHY FOLLOWING TREATMENT OF RHEUMATOID ARTHRITIS WITH ADALIMUMAB, AN ANTI-TNF ALPHA MONOCLONAL ANTIBODY
    Kolluru, Sarath
    Ahmed, Waseem
    Misaghian, Negin
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (04) : A48 - A48
  • [46] CLINICAL UTILITY OF RANDOM ANTI-TNF DRUG LEVEL TESTING AND MEASUREMENT OF ANTI-DRUG ANTIBODIES ON LONG-TERM TREATMENT RESPONSE IN RHEUMATOID ARTHRITIS
    Jani, Meghna
    Chinoy, Hector
    Warren, Richard B.
    Griffiths, Christopher E. M.
    Plant, Darren
    Fu, Bo
    Morgan, Ann W.
    Wilson, Anthony G.
    Isaacs, John D.
    Hyrich, Kimme L.
    Barton, Anne
    RHEUMATOLOGY, 2015, 54 : 27 - 28
  • [47] TNF alpha promoter polymorphism influences outcome of anti-TNF alpha therapy in rheumatoid arthritis.
    Mugnier, B
    Balandraud, N
    Darque, A
    Mercier, P
    Roudier, C
    Roudier, J
    Reviron, D
    GENES AND IMMUNITY, 2004, 5 : S34 - S34
  • [48] THE IMPACT OF ANTINUCLEAR ANTIBODIES INDUCED BY ANTI-TUMOUR NECROSIS FACTOR ALPHA AGENTS ON THE LONG-TERM TREATMENT OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTS
    Santos Oliveira, D.
    Martins, A.
    Martins, F. R.
    Rato, M.
    Oliveira Pinheiro, F.
    Fonseca, D.
    Garcia, S.
    Fernandes, B. M.
    Vaz, C.
    Bernardes, M.
    Costa, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 476 - 477
  • [49] Predicting response to anti-TNFα therapy among patients with rheumatoid arthritis
    Hyrich, K
    Watson, K
    Symmons, D
    Silman, A
    RHEUMATOLOGY, 2005, 44 : I24 - I24
  • [50] Concomitant Hydroxychloroquine Impact on Anti-TNF Persistence in Patients with Rheumatoid Arthritis
    Zhao, Ming
    Sayles, Harlan
    O'Dell, James R.
    Michaud, Kaleb
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345